Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia
Joel M. Palefsky
, Anna R. Giuliano
,
Stephen Goldstone
, Edson D. Moreira
, Carlos Aranda
, Heiko Jessen
, Richard Hillman
, Daron Ferris
, Francois Coutlee
, Mark H. Stoler
, J. Brooke Marshall
, David Radley
, Scott Vuocolo
, Richard M. Haupt
, Dalya Guris
, Elizabeth I.O. Garner
Icahn School of Medicine at Mount Sinai
Medical Education
Research output
:
Contribution to journal
›
Article
›
peer-review
839
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'HPV vaccine against anal HPV infection and anal intraepithelial neoplasia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Confidence Interval
100%
Human Papillomavirus Vaccine
100%
Papillomavirus Infections
100%
Anal Intraepithelial Neoplasia
100%
Human Papillomavirus 6
62%
Per-protocol
50%
Anal Cancer
50%
Men Who Have Sex with Men
50%
Intention-to-treat
37%
Quadrivalent HPV Vaccine
37%
Placebo Groups
25%
HPV16
25%
High-risk Human Papillomavirus (HR-HPV)
25%
Adverse Events
12%
Healthy Individuals
12%
Placebo
12%
Serious Adverse Events
12%
Efficacy Analysis
12%
Safety Profile
12%
Cancer-related
12%
Anal Infection
12%
Quadrivalent Human Papillomavirus Vaccine
12%
High-grade Anal Intraepithelial Neoplasia
12%
Medicine and Dentistry
Wart Virus Vaccine
100%
Papillomavirus Infection
100%
Anus Carcinoma
100%
Infection
55%
Human Papillomavirus Type 6
55%
Anal Cancer
44%
Men Who Have Sex with Men
44%
Intention-to-Treat Analysis
33%
Placebo
33%
Adverse Event
22%
Wart Virus
22%
Human Papillomavirus Type 18
11%
Human Papillomavirus Type 16
11%